Gout Therapeutics Global Market 2024 To Reach $4.41 Billion By 2028 At Rate Of 11.5%

The Business Research Company’s Gout Therapeutics – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 12, 2024 /EINPresswire.com/ -- The gout therapeutics market has experienced robust growth in recent years, expanding from $2.54 billion in 2023 to $2.86 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increased prevalence of gout, changed lifestyle and dietary patterns, high blood pressure and diabetes prevalence, development of xanthine oxidase inhibitors, patient education initiatives.

Strong Future Growth Anticipated
The gout therapeutics market is projected to continue its strong growth, reaching $4.41 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, advancements in drug delivery systems, emerging novel therapies, government initiatives for chronic disease management, patient advocacy and support groups.

Explore Comprehensive Insights Into The Global Gout Therapeutics Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=12118&type=smp

Growth Driver Of The Gout Therapeutics Market
The rising occurrence of gout is expected to propel the growth of the gout therapeutics market going forward. Gout refers to an inflammatory arthritis condition that causes pain and swelling in joints. Gout therapeutics treat and relieve pain, swelling, and tenderness in joints. As a result, the rising occurrence of gout is expected to boost sales in the gout therapeutics market.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Major Players And Market Trends
Key players in the gout therapeutics market include AbbVie Inc., Sanofi-Aventis, AstraZeneca PLC, LG Chem Ltd., GlaxoSmithKline PLC, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma PLC, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals PLC, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc., BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., Avion Pharmaceuticals LLC, Protalix BioTherapeutics Inc., Teijin Pharma Limited, Romeg Therapeutics LLC., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma.

Major companies operating in the gout therapeutics market are developing innovative products such as corticotropin to enhance product offerings and gain a competitive advantage. Corticotropin, commonly known as adrenocorticotropic hormone (ACTH), is a hormone made up of peptides secreted by the anterior pituitary gland when subjected to low cortisol levels in the blood.

Segments:
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users

Geographical Insights: North America Leading The Market
North America was the largest region in the gout therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by expanding healthcare facilities and increasing awareness of the benefits of gout therapeutics.

Gout Therapeutics Market Definition
Gout therapeutics refers to medication that exerts therapeutic effects in treating the disease condition known as gout, or inflammatory arthritis, which causes pain and swelling in joints. Gout therapeutics treat and relieve pain, swelling, and tenderness in joints.

The main types of gout therapeutics are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and diuretics. Non-steroidal anti-inflammatory drugs (NSAIDs) refer to drugs or medicines used for reducing inflammation, relieving pain, and bringing down a hot temperature. The various treatment includes xanthine oxidase inhibitor, and uricosuria medication used for various disease conditions such as acute, and chronic. These are used by various end-users such as hospitals, specialty clinics, and others.
Gout Therapeutics Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Gout Therapeutics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on gout therapeutics market size, gout therapeutics market drivers and trends, gout therapeutics market major players, gout therapeutics competitors' revenues, gout therapeutics market positioning, and gout therapeutics market growth across geographies. The gout therapeutics market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Pharmaceutical Sterility Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Non-Animal Alternatives Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Electricity And Signal Testing Instruments Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electricity-and-signal-testing-instruments-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Pioneering the Future of Cancer Care: Generic Oncology Drugs Market Insights